期刊
BIOENGINEERED
卷 13, 期 5, 页码 12489-12503出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21655979.2022.2076399
关键词
Bioengineered; miRNA; miR-34a; mitochondria; cancer metabolism
资金
- National Cancer Institute [R01CA225958, R01CA253230]
- National Institute of General Medical Sciences, National Institutes of Health [R35GM140835]
- Hubei Province Scientific and Technological Innovation Key Project [China] [2019ACA136]
- Fundamental Research Funds for the Central Universities [2042020kf0139]
- UC Davis Comprehensive Cancer Center Support Grant - National Cancer Institute [P30CA093373]
This study aims to investigate the role of miR-34a-5p in the regulation of mitochondrial functions in human carcinoma cells using a new bioengineered miRNA molecule. The results show that the bioengineered miR-34a-5p effectively reduces the levels of mitochondrial inner membrane protein MPV17L2, leading to lower respiratory chain activities and intracellular ATP levels. Additionally, the study demonstrates that biologic miR-34a-5p significantly reduces cancer cell mitochondrial respiration capacity and increases oxidative stress and apoptotic cell death.
Genome-derived microRNAs (miRNAs or miRs) control post-transcriptional gene expression critical for various cellular processes. Recently, we have invented a novel platform technology to achieve high-yield production of fully humanized, bioengineered miRNA agents (hBERAs) for research and development. This study is aimed to produce and utilize a new biologic miR-34a-5p (or miR-34a) molecule, namely, hBERA/miR-34a, to delineate the role of miR-34a-5p in the regulation of mitochondrial functions in human carcinoma cells. Bioengineered hBERA/miR-34a was produced through in vivo fermentation production and purified by anion exchange fast protein liquid chromatography. hEBRA/miR-34a was processed to target miR-34a-5p in human osteosarcoma and lung cancer cells, as determined by selective stem-loop reverse transcription quantitative polymerase chain reaction analysis. The mitochondrial inner membrane protein MPV17 like 2 (MPV17L2) was validated as a direct target for miR-34a-5p by dual luciferase reporter assay. Western blot analysis revealed that bioengineered miR-34a-5p effectively reduced MPV17L2 protein outcomes, leading to much lower levels of respiratory chain Complex I activities and intracellular ATP that were determined with specific assay kits. Moreover, Seahorse Mito Stress Test assay was conducted, and the results showed that biologic miR-34a-5p sharply reduced cancer cell mitochondrial respiration capacity, accompanied by a remarkable increase of oxidative stress and elevated apoptotic cell death, which are manifested by greater levels of reactive oxygen species and selective apoptosis biomarkers, respectively. These results demonstrate the presence and involvement of the miR-34a-5p-MPV17L2 pathway in the control of mitochondrial functions in human carcinoma cells and support the utility of novel bioengineered miRNA molecules for functional studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据